Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Shares Outstanding (Weighted Average) (2017 - 2024)

Solid Biosciences (SLDB) has disclosed Shares Outstanding (Weighted Average) for 8 consecutive years, with $41.4 million as the latest value for Q3 2024.

  • Quarterly Shares Outstanding (Weighted Average) rose 109.66% to $41.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $41.4 million through Sep 2024, up 109.66% year-over-year, with the annual reading at $19.9 million for FY2023, 133.6% up from the prior year.
  • Shares Outstanding (Weighted Average) hit $41.4 million in Q3 2024 for Solid Biosciences, up from $40.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $112.3 million in Q2 2021 to a low of $3.5 million in Q4 2020.
  • Historically, Shares Outstanding (Weighted Average) has averaged $31.3 million across 5 years, with a median of $19.8 million in 2023.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 93.31% in 2022 and later soared 162.81% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $3.5 million in 2020, then soared by 105.58% to $7.1 million in 2021, then increased by 19.58% to $8.5 million in 2022, then soared by 133.6% to $19.9 million in 2023, then surged by 108.43% to $41.4 million in 2024.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SLDB at $41.4 million in Q3 2024, $40.9 million in Q2 2024, and $38.2 million in Q1 2024.